RxDoctor Payments Data

Gary Brickner, MD

Obstetrics & Gynecology · Hamilton, NJNPI 1699796607

Payments from drug & device makers

$2,738in general payments, 2019–2025

Across 166 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$623
  • Myovant Sciences Inc.$280
  • Astellas Pharma US Inc$256
  • Sumitomo Pharma America, Inc.$217
  • Exeltis, USA Inc.$208
  • Pfizer$162
  • plus $992 from 23 others

What the payments were for

  • Food & beverage$2,738100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,738 in reported general payments places this provider in the 80th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

See all obstetrics & gynecology providers in New Jersey

Medicare billing

Part B allowed, 2024
$21,398
Medicare patients
133
Services billed
314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol112$10,859
PremarinEstrogens, Conjugated11$7,681
Risedronate Sodium12$2,754
PremproEstrogen,con/M-Progest Acet12$2,753
ValacyclovirValacyclovir Hcl34$1,711
Solifenacin Succinate16$1,625
Raloxifene Hcl45$1,587
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip72$1,032
Ibandronate Sodium18$732
Fluconazole81$332
Amitriptyline Hcl17$246
Triamcinolone Acetonide28$214
Metronidazole11$171
Clobetasol Propionate15$169
Alprazolam17$124

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin, Prempro$162$10,43323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

Other obstetrics & gynecology in Hamilton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →